Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer

Oncology Reports

Volumn 16, Issue 3, 2006, Pages 457-463

  Oida, Yasuhisa ^a   Yamazaki, Hitoshi ^a   Tobita, Kosuke ^a   Mukai, Masaya ^a   Ohtani, Yasuo ^a   Miyazaki, Noriyuki ^a   Abe, Yoshiyuki ^a   Imaizumi, Toshihide ^a   Makuuchi, Hiroyasu ^a   Ueyama, Yoshito ^a   Nakamura, Masato ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

E cadherin; Metastasis; Pancreatic cancer; Prognosis; S100A4

Indexed keywords

CADHERIN; PROTEIN S 100; S100A4 PROTEIN, HUMAN;

AGED; ARTICLE; CANCER STAGING; FEMALE; GENE EXPRESSION REGULATION; HUMAN; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; PERITONEUM TUMOR; PROGNOSIS;

AGED; AGED, 80 AND OVER; CADHERINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PERITONEAL NEOPLASMS; PROGNOSIS; S100 PROTEINS;

EID: 33749181260     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.3.457     Document Type: Article

References (33)

1. Murr MM, Sarr MG, Oishi AJ and Van Heerden JA: Pancreatic cancer. CA. Cancer J Clin 44: 304-318, 1994. (Pubitemid 24306038)
2. Iwamura T, Katsuki T and Ide K: Establishment and characterization of a human pancreatic cacer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. Jpn J Cancer Res 78: 54-62, 1987. (Pubitemid 17037867)
3. Shafer BW and Heizmann CW: The S100 family of EF-hand calcium binding proteins: functions and pathology. Trends Biochem Sci 21: 134-140, 1996.
4. Watanabe Y, Kobayashi R, Ishikawa T and Hidaka H: Isolation and characterization of a calcium-binding protein derived from synthesized vasorelaxant W-66 affinity chromatography. Arch Biochem Biophys 292: 563-569, 1992.
5. 2+-binding protein family. Genes Dev 3: 1086-1093, 1989.
6. Mazzucchelli L: Protein S100A4: too long overlooked by pathologists? Am J Pathol 160: 7-13, 2002.
7. Davies BR, Davies MP, Gibbs FE, Barraclough R and Rudland PS: Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene 8: 999-1008, 1993. (Pubitemid 23087433)
8. Grigorian M, Ambertsumian N, Lykkesfeldt AE, Bastholm L, Elling F, Georgiev G and Lukanidin E: Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int J Cancer 67: 831-841, 1996. (Pubitemid 26348813)
9. Davies MPA, Rudland PS, Robertson L, Parry E, Jolicocur P and Barraclough R: Expression of calcium binding protein S100A4 in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene 13: 1631-1637, 1996. (Pubitemid 26377494)
10. Lloyd BH, Platt-Higgins A, Rudland PS and Barraclough R: Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells. Oncogene 17: 465-473, 1998. (Pubitemid 28395911)
11. Barraclough R: Calcium binding protein S100A4 in health and disease. Biochim Biophys Acta 1448: 190-199, 1998.
12. Yonemura Y, Endou Y, Kimura K, Fushida S, Bandou E, Taniguchi K, Kinoshita K, Ninomiya I, Sugiyama K, Heizmann CW, Schafer BW and Sasaki T: Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 6: 4234-4242, 2000.
13. Gongoll S, Peters G, Mengel M, Piso P, Klempnauer J, Kreipe H and Wasielewski RV: Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 123: 1478-1484, 2002. (Pubitemid 35231647)
14. Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JH, Robertson L and Barraclough R: Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60: 1595-1603, 2000. (Pubitemid 30183430)
15. Nakamura T, Ajiki T, Murao S, Kamigaki T, Maeda S, Ku Y and Kuroda Y: Prognostic significance of S100A4 expression in gallbladder cancer. Int J Oncol 20: 937-941, 2002.
16. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991.
17. Wheelock MJ and Jensen PJ: Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin. J Cell Biol 117: 415-425, 1992.
18. Hirohashi S: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153: 333-339, 1998.
19. Pignatelli M, Ansari TW, Gunter P, Liu D, Hirano S, Takeichi M, Kloppel G and Lemoine NR: Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 174: 243-248, 1994.
20. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D and Birchmeier W: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991. (Pubitemid 21909684)
21. Behrens J, Mareel MM, Van Roy FM and Birchmeier W: Dissecting tumor cell invasion: epithelial cells acquire invasion properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108: 2435-2447, 1989. (Pubitemid 19168932)
22. Kohya N, Kitajima Y, Jiao W and Miyazaki K: Effects of E-cadherin transfection on gene expression of a gall bladder carcinoma cell line: Repression of MTS1/S100A4 gene expression. Int J Cancer 104: 44-53, 2003. (Pubitemid 36184145)
23. Kimura K, Endo Y, Yonemura Y, Heizmann CW, Schäfer BW, Watanabe Y and Sasaki T: Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int J Oncol 16: 1125-1131, 2000.
24. TNM classification of Malignant Tumors. Sobin LH and Wittekind CH (eds). Wiley-Liss, New York, pp87-90, 1997.
25. Klöppel G and Maillet B: Histological typing of pancreatic and periampullary carcinoma. Eur J Surg Oncol 17: 139-152, 1991.
26. Moriyama-Kita M, Endo Y, Yoneyama Y, Heizmann CW, Schäfer BW, Sasaki T and Yamamoto E: Correlation of S100A4 expression with invasion and metastasis in oral squamous cell carcinoma. Eur J Cancer B Oral Oncol 40: 496-500, 2004. (Pubitemid 38296834)
27. Takenaga A, Nakamura Y, Endo H and Sakiyama S: Involvement of S100 related calcium binding protein pEL98 (or mts1) in cell motility and tumor cell invasion. Jpn J Cancer Res 85: 831-839, 1994. (Pubitemid 24262305)
28. Ford HL, Salim MN, Chakravarty R, Aluiddin V and Zain SB: Expression of mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line. Oncogene 11: 2067-2075, 1995.
29. Grigorian MS, Tulchinsky EM, Zain S, Ebralidze AK, Kramerov DA, Kriajevska MV, Georgiev GP and Lukanidin EM: The mts1 gene and control of tumor metastasis. Gene 135: 229-238, 1993. (Pubitemid 24042957)
30. Mælandsmo GM, Hoving E, Skrede M, Engebraaten O, Florenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ and Fodstad O: Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res 56: 5490-5498, 1996. (Pubitemid 27011385)
31. Keirseblick AB, Bonne S, Bruyneel E, Vermassen P, Lukanidin E, Mareel M and van Roy F: E-cadherin and metastasin (mts-1/S100A4) expression levels are inversely regulated in two tumor cell families. Cancer Res 58: 4587-4591, 1998. (Pubitemid 28480620)
32. Anderson K, Nesland JM, Holm R, Florenes VA, Fodstad O and Mælandsmo GM: Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma. Mod Pathol 17: 990-997, 2004. (Pubitemid 38993784)
33. Li YJ, Meng YX and Ji XR: Relationship between expression of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer. HBPD Int 2: 471-477, 2003.